Core Insights - The beauty giant L'Oréal has selected 13 companies for its "L'AcceleratOR" accelerator program after reviewing nearly 1,000 applications from 101 countries, focusing on biomanufacturing solutions [1][14]. Group 1: L'AcceleratOR Program - The "L'AcceleratOR" program, launched in June 2025 in collaboration with the University of Cambridge's Institute for Sustainability Leadership (CISL), aims to donate €100 million (approximately 800 million RMB) over five years and provide 12 months of resource support to selected projects [3][16]. - The selected companies are expected to promote their solutions within L'Oréal's international business [3][16]. Group 2: Selected Companies - Six of the 13 selected companies are focused on bio-based materials, including: - Kelpi, which has developed a biodegradable coating made from seaweed that offers similar protective qualities to plastic [4][17]. - Bioworks, which has created a bio-based packaging material, PlaX, from sugarcane, reducing carbon emissions by 62% compared to traditional petroleum-based plastics [4][17]. - Blue Ocean Closures, which produces caps from dried plant fibers as an alternative to plastic [6][19]. - RAIKU, which can convert one cubic meter of wood into 203 units of packaging material, reducing wood usage by 90% [6][19]. - Purpex, which is developing recyclable paper bottles [20]. - Novobiom, REPLACE, and Gàs Verde, which focus on circular solutions using fungi, multi-layer plastics, and biogas production, respectively [20]. Group 3: L'Oréal's Investment Strategy - L'Oréal has been actively investing in synthetic biology, having made nine investments in related companies since 2022, with a focus on developing natural active ingredients and alternatives to traditional raw materials [10][23]. - The company's venture capital arm, BOLD, has been investing in beauty startups since its establishment in 2018, with a strong emphasis on biotechnology and green science [10][23]. Group 4: Recent Collaborations - Recent collaborations include investments in companies such as Microphyt for extracting natural ingredients from microalgae, Genomatica for developing palm oil using fermentation technology, and partnerships with various Chinese biotech firms [12][25]. - Notable Chinese companies include: - Blue Ocean Microbiology, known for its biodegradable plastic PHA, with total financing exceeding 1.9 billion RMB [13][26]. - Shanhai Innovation, which collaborates with over 100 companies, including L'Oréal [13][26]. - Weiming Shiguang, focusing on high-value bioactive materials for beauty and personal care [13][26].

一旁的同创伟业合伙人张鹏也提到："我们和常德2022-2023年开始基金层面合作，最初没料到内地城市 能有这么好的营商环境。"他笑称，常德政府的办事效率和领导风格"更像沿海地区"，这种超预期的体 验让企业落地格外顺畅。双方合作的一期基金基本完成了投资工作，现在开始筹备规模更大的二期基 金，已经落地的项目中有两家实现了一年内营收从0破千万。 投资机构纷至沓来 以前的常德，桃花源的田园诗意与"芙蓉王"铸就的工业传奇是它的城市标签。这座曾长期依赖烟草产业 的城市，在最近的几年内竟悄然崛起为合成生物产业高地，成为全国重要的甾体原料药和中间体生产出 口基地。 "常德做合成生物学为什么相对成功？它不是跟风的。"在大赛间隙的交流中，东方富海合伙人陈华伟很 认真地表示。他指出，常德在合成生物学领域的布局并非追逐热点，而是在2022年前后，在全国范围内 与合成生物学方向的院士专家、投资机构的系统调研和内部多次培训后，结合本地资源禀赋做出的战略 决策。 基于常德独有的产业基础，才有了之后的快速发展。据他介绍，常德在传统生物发酵领域本身拥有基 础，例如作为全国重要的培养基基地，为产业发展提供了独特的人才和要素支撑。 目前，东方富海 ...

在全球推进绿色转型与"双碳"目标的战略背景下，生物基化学品与材料作为生物制造产业的核心支柱，凭借原料可再生、全生命周期低碳环保等核心 优势，正加速替代传统石油基产品，在包装、纺织、汽车等领域展现出广阔应用前景，成为全球产业绿色转型的关键赛道。 我国高度重视该领域发展，将生物基新材料列为关键战略材料，多项产业扶持政策持续落地。然而，产业仍面临包括综合成本竞争力、原料供应链稳 定、产品性能优化及终端市场接受度等关键问题。 基于此， 2026年3月31日-4月1日 ，"第五届中国合成生物学及生物制造大会"将在杭州举办，其中设置 【 生物基化学品与材料专场】 ，旨在汇聚产学 研用多方智慧，破解产业发展难题，助力生物基化学品与材料产业高质量发展。 大会介绍 0 1 大会时间 | 2026年3月31日-4月1日 大会地点 | 杭州市 大会规模 | 1000人 主办单位 | synbio深波 承办单位 | 享融智云 媒体支持 | synbio新农食、synbio新美护、synbio新材料、生物制造圈、合成生物学俱乐部 扫码 免费 报名参会 ↓↓↓ 论坛设置 0 2 | | 会场一 | 会场二 | 会场三 | | --- | ...

Core Viewpoint - The company aims to focus on high-quality growth in its core business and aspires to become a leading enterprise in synthetic biology, positioning itself as a competitive industry leader in the amino acid sector [1] Group 1: Strategic Focus - The company is committed to becoming a "lighthouse factory" in the amino acid industry, emphasizing the importance of technological and management leadership as dual drivers for growth [1] - The company plans to enhance its competitive edge by advancing research and development, supply chain, production, sales, and various functional departments simultaneously [1] Group 2: Corporate Values - The company emphasizes a commitment to creating and sharing value, maintaining a customer-centric approach, and upholding integrity as fundamental principles [1]

Group 1 - The article emphasizes the importance of bio-based chemicals and materials as a core pillar of the bio-manufacturing industry, highlighting their advantages such as renewable raw materials and low carbon emissions throughout their lifecycle, which positions them as key players in the global green transition [2] - The Chinese government prioritizes the development of bio-based new materials, categorizing them as strategic materials, and has implemented multiple supportive policies for the industry [2] - Despite the growth potential, the industry faces challenges including cost competitiveness, stability of raw material supply chains, product performance optimization, and market acceptance [2] Group 2 - The "5th China Synthetic Biology and Bio-Manufacturing Conference" is scheduled to take place in Hangzhou from March 31 to April 1, 2026, aiming to gather insights from various sectors to address industry challenges and promote high-quality development of bio-based chemicals and materials [2][4] - The conference will feature multiple forums, including a dedicated session on bio-based chemicals and materials, alongside other relevant topics such as bio-manufacturing technology and applications [8] - The event is expected to attract around 1,000 participants, providing opportunities for networking and collaboration among industry stakeholders [4]

声明： 因水平有限，错误不可避免，或有些信息非最及时，欢迎留言指出。本文由仅作新材料相关领域介绍，本文不构成任何投资 建议！转载请注明来源！ 据" 华澄生物 "消息， 近日，金桥基金完成对 江苏华澄生物科技有限公司 （下称"华澄生物"） 天使轮 融资 。此次融资将重点用于核心技术迭代、团队扩充、市场开拓以及中试产线建设等关键业务，加速 推进 生物基色素 的商业落地。 华澄生物 是一家专注于高性能生物基染料的科技型创新企业。 旨在 通过合成生物技术，研发出红、 黄、蓝、黑等一系列生物基染料 ，为全球用户提供更安全、更可持续的色彩解决方案。 以合成生物学为底层引擎，重构染料制造方式。华澄生物通过代谢工程将微生物改造成"细胞工厂"，以 再生物质为原料，优化发酵工艺，产出生物基染料。与化工染料相比，大大降低废水处理的成本和能 耗， 彻底摆脱高盐、高苯胺排放与重金属残留的行业痛点 ，为纺织行业提供可规模化的清洁染色源头 方案。 且更安全更环保。我相信此次合作成功，将会加速华澄生物的技术成果商业化应用，为"中国制 造"向"中国创造"升级再添标杆案例。 金桥基金高级投资经理陈伟表示： 在健康消费浪潮与政策监管双向驱动下，叠 ...

Core Viewpoint - The article discusses the upcoming 2026 Bio-based Conference and Exhibition in Shanghai, focusing on the collaboration between Huaheng Biological and academic institutions to advance amino acid applications in animal nutrition, emphasizing the importance of non-essential amino acids in sustainable livestock production [2][4][8]. Group 1: Event Overview - The 2026 Bio-based Conference will take place from May 20-22 in Shanghai, featuring 11 thematic forums, 7 concurrent activities, over 1000 new product displays, and an industry award ceremony [2][11]. - The conference aims to create an efficient platform for upstream and downstream industry connections, promoting low-carbon and green transformation in the sector [2]. Group 2: Collaboration and Research - Huaheng Biological has signed a strategic cooperation agreement with academician Yin Yulong and his team to focus on innovative research and industrial application of amino acids in animal nutrition [4][5]. - The collaboration aims to convert research outcomes into efficient and environmentally friendly feed additives, enhancing animal health and production performance [4]. Group 3: Importance of Non-Essential Amino Acids - Non-essential amino acids (NEAAs) play a crucial role in enhancing gut immunity, maintaining gut health, and improving animal growth performance while reducing antibiotic use and heavy metal emissions [4][6]. - The demand for NEAAs increases significantly during immune stress conditions, with specific amino acids like glutamine and arginine showing a 2-3 times higher requirement during peak immune responses [6][7]. Group 4: Advances in Amino Acid Production - Synthetic biology is revolutionizing the production of amino acids, with Huaheng Biological collaborating with academician Zheng Yuguo's team to establish a 3000-ton/year bio-based L-methionine production line [8][10]. - The team has developed key technologies for the efficient synthesis of L-methionine precursors, achieving the highest domestic and international production rates [10].

Core Viewpoint - The article highlights the participation of Jiangsu Huacheng Biotechnology Co., Ltd. in the 2026 DT New Leaf Award, focusing on its innovative bio-based blue pigment and green dyeing solutions aimed at promoting sustainable practices in the textile industry [2][13]. Group 1: Company Overview - Jiangsu Huacheng Biotechnology Co., Ltd. was established in 2024, focusing on synthetic biology research and product commercialization, particularly in bio-based materials and biochemicals for pharmaceuticals, cosmetics, food, and health products [3]. - The company aims to drive industrial upgrades through technological innovation, emphasizing large-scale bio-manufacturing of food colorants, chemical dyes, and functional food ingredients [3]. Group 2: Bio-based Blue Pigment - The bio-based blue pigment is produced using synthetic biology techniques, utilizing engineered microorganisms as "cell factories" for efficient fermentation [4]. - Compared to chemical dyes, bio-based dyes are natural, non-toxic, and exhibit excellent antibacterial and anti-yellowing properties, with lower damage to high-end fabrics like silk and wool [4][10]. - The production process avoids traditional petroleum-based methods, reducing harmful substance generation and wastewater treatment costs, while achieving USDA bio-based product certification [8][10]. Group 3: Green Dyeing Solutions - Traditional chemical dyes pose significant health and environmental risks, leading to complex pollution issues in the textile industry [9]. - Huacheng's approach involves replacing chemical dyes with bio-based alternatives, providing scalable clean dyeing solutions that align with national environmental goals [9]. - The innovative process utilizes renewable carbon sources and mild fermentation conditions, significantly lowering wastewater chemical oxygen demand and overall energy consumption [9]. Group 4: Awards and Recognition - The DT New Leaf Award features four categories: Innovation Material Award, Innovation Application Award, Most Commercially Valuable Award, and Innovative Industry Solution Award, with the first round of applications closing on February 10, 2026 [5][13]. - Huacheng's participation in the award reflects its commitment to sustainable practices and innovation in the bio-based industry [2][13].

Summary of Key Points from Conference Call Records Industry Overview - **Consumer Sector**: The consumer sector showed weakness in Q4 2026, with retail sales growth of only 0.7% year-on-year. Key categories like home appliances, furniture, and petroleum products experienced declines. Durable goods faced challenges due to subsidy exhaustion and falling real estate sales [1][3] - **Service Consumption**: Service consumption grew by 5.5% year-on-year in December 2026, benefiting from consumption upgrades and government support. The overall growth for the year is expected to reach 6.5% [1][4][5] - **E-commerce Tax Impact**: The introduction of e-commerce tax has significantly impacted the industry in the short term, leading to a decline in growth rates for platforms like Douyin and Alibaba. However, it may promote fair competition and improve the survival rate of quality brands in the long term [2][17] Company-Specific Insights - **Li Ning**: The brand's retail sales in Q4 showed a minor decline, with online sales stable and offline sales decreasing. The company is focusing on popular shopping districts and has plans for marketing initiatives around the Winter Olympics [1][8][10] - **Leisure Company (乐舒氏)**: The company is rapidly growing in emerging markets, with a projected revenue increase of 19% and a net profit growth of 127% in 2024. It has established a strong presence in Africa and is expanding into Latin America and Central Asia [1][11][12] - **TCL Electronics**: The company is expected to benefit from a strong brand presence due to major sports events in 2026. Profit margins are recovering, and the stabilization of panel prices is favorable for long-term growth [1][15] - **Hong Kong Restaurant Chains**: Recommended companies include Hai Tian International, Yi Hai International, and Wei Long, with potential for valuation recovery and growth driven by improved supply chain dynamics [1][7][24] Market Trends and Predictions - **Tool Chain Industry**: The tool chain industry is experiencing a positive trend, with inventory levels at historical lows and expectations of interest rate cuts in the US. This could lead to significant upside potential for companies like 全丰控股 [1][14] - **Travel Industry (携程)**: Despite facing antitrust investigations, the company maintains strong competitive advantages. A $5 billion share buyback plan is expected to support stock prices, and long-term valuation remains reasonable [1][19][20] Additional Insights - **Durable Goods Outlook**: The future of durable goods is uncertain, with potential improvements contingent on stabilization in the real estate market. Current growth is primarily driven by service consumption [1][6] - **Investment Opportunities**: The restaurant sector presents investment opportunities due to low valuations and attractive dividend yields. Companies like 百胜 and 海底捞 are highlighted for their potential [1][24] This summary encapsulates the key points from the conference call records, providing insights into industry trends, company performances, and market predictions.

首个管线已进入II期临床阶段。 本文为IPO早知道原创 作者｜ C叔 微信公众号｜ipozaozhidao 据IPO早知道消息，近日，浙江德进生物医药科技有限公司（下称"德进生物"）完成数千万元A轮融 资，由弘晖基金领投，凯乘资本担任首席财务顾问并继续负责后续融资。融资金额将主要用于推进公 司核心产品——基于合成生物学平台开发的重组肉毒素的临床研究、产业化基地建设及国际化布局。 德进生物是一家专注于重组肉毒素研发、生产和销售的创新企业，致力于将合成生物学技术应用于药 学领域，研发和提供性价比卓越的肉毒素系列产品，最终成为该品类主要供应商之一。 在技术创新层面，基于公司自有专利技术，德进生物的首个管线"DJ-01注射剂"已进入II期临床阶 段，安全性和有效性良好；该产品基于基因工程菌株设计与构建技术平台开发，显著降低传统肉毒素 生产中突出的生物安全风险，在大幅提高产品纯度和质量的同时还能保持极具竞争力的成本，充分发 挥出工程菌株设计平台以及重组蛋白技术优势。 在产业化层面，德进生物核心团队成员工作时间均在十年以上，在重组蛋白研发、生物药开发、高活 性药厂建设、药品生产以及医美市场开拓领域拥有丰富经验。在公司建立 ...